1. Acute haemodynamic effects of felodipine in congestive heart failure

   • H. Emanuelsson
   • Å. Hjalmarson
   • F. Waagstein

   Originals Pages: 489 - 493

2. Effect of pinacidil on blood pressure, plasma catecholamines and plasma renin activity in essential hypertension

   • G. Muiesan
   • R. Fariello
   • O. E. Christensen

   Originals Pages: 495 - 499

3. Haemodynamic effects of indenolol at rest and after a submaximal workload in essential hypertension

   • C. Aiello
   • G. Groothold
   • A. Romano

   Originals Pages: 501 - 505

4. A comparison of labetalol and prazosin combined with atenolol in non-responders to atenolol plus hydrochlorothiazide in uncomplicated hypertension

   • E. van der Veur
   • B. S. ten Berge
   • H. Wesseling

   Originals Pages: 507 - 511

5. Effects of prazosin and alphamethyldopa on blood lipids and lipoproteins in hypertensive patients

   • M. Velasco
   • H. Silva
   • O. Hernández-Pieretti

   Originals Pages: 513 - 516

6. Protective effect by UCB JO28 against histamine and methacholine induced bronchial hyperreactivity

   • F. P. V. Maesen
   • J. J. Smeets
   • J. P. Rihoux

   Originals Pages: 517 - 521

7. Peripheral antihistamine and central sedative effects of three H₁-receptor antagonists

   • S. Levander
   • Ö. Hägermark
   • M. Ståhle

   Originals Pages: 523 - 529

8. Assessment of the antimineralocorticoid effect of RU 28318 in healthy men with induced exogenous and endogenous hypermineralocorticism

   • A. Ulmann
   • C. Bertagna
   • P. Corvol

   Originals Pages: 531 - 535

9. Overestimation of renal function in glucocorticosteroid treated patients

   • F. F. Horber
   • J. Scheidegger
   • F. J. Frey

   Originals Pages: 537 - 541

10. Evaluation of infusion regimens for thiopentone as a primary anaesthetic agent

    • D. P. Crankshaw
    • N. E. Edwards
    • D. J. Morgan

    Originals Pages: 543 - 552

11. Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram

    • L. Bjerkenstedt
    • L. Flyckt
    • O. Lingjærde

    Originals Pages: 553 - 557

12. Interaction of diazepam or lorazepam with alcohol

    • K. Aranko
    • T. Seppälä
    • M. J. Mattila

    Originals Pages: 559 - 565

13. Psychopharmacological effects of vinpocetine in normal healthy volunteers

    • Z. Subhan
    • I. Hindmarch

    Originals Pages: 567 - 571

14. Pharmacokinetics of tolfenamic acid in patients with cirrhosis of the liver

    • J. Stenderup
    • J. Eriksen
    • L. V. Christiansen

    Originals Pages: 573 - 579

15. The influence of ascites on the pharmacokinetics of piretanide in cirrhotic patients

    • A. N. Shepherd
    • I. A. D. Bouchier

    Originals Pages: 581 - 583

16. Effect of impairment of renal function on the accumulation and disposition of isoxicam

    • R. W. Bury
    • J. A. Whitworth
    • R. F. W. Moulds

    Originals Pages: 585 - 588

17. Antipyrine metabolite formation and excretion in patients with chronic renal failure

    • M. W. E. Teunissen
    • D. Kampf
    • D. D. Breimer

    Originals Pages: 589 - 595

18. Transfer of labetalol into amniotic fluid and breast milk in lactating women

    • N. O. Lunell
    • J. Kulas
    • A. Rane

    Originals Pages: 597 - 599

19. Interactions between smectite, a mucus stabilizer, and acidic and basic drugs

    • E. Albengres
    • S. Urien
    • K. Drieu

    Originals Pages: 601 - 605

20. Evidence for a GABAergic control of the exercise-induced rise in GH in man

    • L. Steardo
    • M. Iovino
    • F. Orio

    Short Communications Pages: 607 - 609

21. Pharmacokinetics of an extended-release dosage form of molsidomine in patients with coronary heart disease

    • J. Ostrowski
    • G. Gaul
    • K. Resag

    Short Communications Pages: 611 - 613